SLN — Silence Therapeutics plc stock price, charts and financials

QT66Silence Therapeutics plc

Silence Therapeutics plc (NASDAQ: SLN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.17
+0.49+4.59%
OverviewShort InterestFilings
SLNQT66Silence Therapeutics plc·NASDAQ
11.17+4.59%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 16, 20268-K/ACurrent report (amended)
Jul 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 07, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 11, 20268-KCurrent report
May 27, 2026424B5Prospectus
May 27, 2026EFFECTNotice of effectiveness
May 18, 20268-KCurrent report
May 18, 2026S-3Shelf registration statement
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 29, 2026ARSAnnual report to shareholders
Apr 29, 2026DEF 14ADefinitive proxy statement
Mar 05, 202610-KAnnual report
Mar 05, 2026S-8Registration of employee benefit securities
Mar 05, 20268-KCurrent report
Feb 13, 20264Statement of changes in beneficial ownership
Feb 09, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 06, 20264Statement of changes in beneficial ownership
Jan 06, 20264Statement of changes in beneficial ownership
Jan 06, 20264Statement of changes in beneficial ownership
Jan 06, 20264Statement of changes in beneficial ownership
Jan 06, 20264Statement of changes in beneficial ownership
Dec 22, 20254Statement of changes in beneficial ownership
#1 / 25 of 193
Page
▼
/ 8